» Articles » PMID: 26359465

International Variation in Female Breast Cancer Incidence and Mortality Rates

Overview
Date 2015 Sep 12
PMID 26359465
Citations 301
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related death among women worldwide. Herein, we examine global trends in female breast cancer rates using the most up-to-date data available.

Methods: Breast cancer incidence and mortality estimates were obtained from GLOBOCAN 2012 (globocan.iarc.fr). We analyzed trends from 1993 onward using incidence data from 39 countries from the International Agency for Research on Cancer and mortality data from 57 countries from the World Health Organization.

Results: Of 32 countries with incidence and mortality data, rates in the recent period diverged-with incidence increasing and mortality decreasing-in nine countries mainly in Northern/Western Europe. Both incidence and mortality decreased in France, Israel, Italy, Norway, and Spain. In contrast, incidence and death rates both increased in Colombia, Ecuador, and Japan. Death rates also increased in Brazil, Egypt, Guatemala, Kuwait, Mauritius, Mexico, and Moldova.

Conclusions: Breast cancer mortality rates are decreasing in most high-income countries, despite increasing or stable incidence rates. In contrast and of concern are the increasing incidence and mortality rates in a number of countries, particularly those undergoing rapid changes in human development. Wide variations in breast cancer rates and trends reflect differences in patterns of risk factors and access to and availability of early detection and timely treatment.

Impact: Increased awareness about breast cancer and the benefits of early detection and improved access to treatment must be prioritized to successfully implement breast cancer control programs, particularly in transitioning countries.

Citing Articles

Real-World Observational Study of Incidence and Outcomes in an HR+/HER2- Early Breast Cancer Population with High-Risk of Recurrence in Finland.

Singh R, Tuominen S, Lassenius M, Auvinen M, Torstensson A, Wiklund T Oncol Ther. 2025; 13(1):185-200.

PMID: 39951234 PMC: 11880475. DOI: 10.1007/s40487-024-00324-0.


Prevalence of Breast Cancer-Related Lymphedema in Israeli Women Following Axillary Procedures.

Kedar D, Zvi E, Haran O, Sherker L, Sernitski M, Oppenheim N J Clin Med. 2025; 14(3).

PMID: 39941369 PMC: 11818719. DOI: 10.3390/jcm14030688.


Predictors of survival rates among breast cancer patients in Ethiopia: a systematic review and meta-analysis 2024.

Mulugeta C, Emagneneh T, Kumie G, Sisay A, Abebaw N, Ayele M Arch Public Health. 2025; 83(1):30.

PMID: 39910659 PMC: 11800556. DOI: 10.1186/s13690-025-01514-6.


Trends and ethnic disparity in endometrial cancer mortality in South Africa (1999-2018): A population-based Age-period-cohort and Join point regression analyses.

Olorunfemi G, Libhaber E, Ezechi O, Musenge E PLoS One. 2025; 20(1):e0313487.

PMID: 39854486 PMC: 11759400. DOI: 10.1371/journal.pone.0313487.


Female healthcare undergraduates' scientific readiness for raising breast cancer awareness in Syrian conservative community.

Alshafie M, Bitar A, Alameer M, Alhomsi D, Alfawal M, Saifo M BMC Med Educ. 2025; 25(1):111.

PMID: 39849495 PMC: 11755823. DOI: 10.1186/s12909-024-06586-6.